Trivedi Global Inc. Announces Research Results of Eileen Meaghers Energy...
Preclinical research suggests more than 40 decrease in expression of inflammatory biomarkers.CHATTANOOGA Tenn. PRWEB July 12 2018 Eileen Meagher an evidencebased energy healer announces today...
View ArticleTrivedi Global Inc. and Carola Sand Announce Research Results on the Impact...
Over 120 increase in overall immunity seen in the preclinical research.HELSINKI PRWEB July 12 2018 Carola Marina Sand a scientifically validated energy healer today announces research results based on...
View ArticleTrivedi Global Inc. and Dr. William Plikerd Announce Results on the Impact of...
Expression of inflammatory biomarkers reduced by over 40 as seen in the preclinical research.COLUMBUS Ohio PRWEB July 12 2018 Dr. William Plikerd an evidencebased healer today announces research...
View ArticleTrivedi Global Inc. with Dimitrius Anagnos Announces Research Results of a...
Overall immunity increased by greater than 150. The research suggests that this proprietary holistic treatment fights against inflammation and improves stress management as well as antiaging with a...
View ArticleTrivedi Global Inc. and Barry Wellborn Announce Research of Biofield Energy...
Immunity increased by over 110. The data also supports the potential of this biofield energy treated formulation to be useful in improvement of overall health and quality of life based on several...
View ArticleLandos Biopharma Initiates Phase 1 Clinical Trial of BT11 an Oral LANCL2...
Landos Biopharma Inc. a clinicalstage biopharmaceutical company focused on developing improved treatments for autoimmune diseases announced today that the first healthy subjects have been dosed in a...
View ArticleJanssen launches Phase IIIII program of Crohn's disease candidate
Janssen Research & Development initiated the Phase IIIII GALAXI program to assess the safety and efficacy of Tremfya or gus More
View ArticleTrivedi Global Inc. and Jay Prague Announce Research Results on the Impact of...
Inflammatory biomarkers decreased by over 30 percent.HOUSTON PRWEB July 12 2018 Jay A. Prague an energy healer with scientifically validated abilities today announces the outcome of preclinical...
View ArticleTrivedi Global Inc. with Alan Balmer Announces Research Results of a...
Overall immunity increased by greater than 150. The preclinical research assessed biomarkers for systemic and organspecific inflammation and blood as well as immune function.LAS VEGAS PRWEB July 12...
View ArticleTrivedi Global Inc. and Alan Balmer Announce the Research Results of a...
70 decrease in expression of inflammatory biomarkers. The preclinical research assessed biomarkers for systemic and organspecific inflammation as well as immune function response.LAS VEGAS PRWEB July...
View ArticleTrivedi Global Inc. with Victoria Vannes Announce Research Results on an...
40 reduction in expression of inflammatory biomarkers seen in the preclinical research. The results of this alternative medicinebased approach suggest benefits for antiaging and stress management by...
View ArticleTrivedi Global Inc. and TC Slade Announce Research Results on the Impact of a...
Overall immunity increased by over 250.DURANGO Colo. PRWEB July 13 2018 TC Slade an evidencebased energy healer today announces research based on the impact of a biofield energy treated nutraceutical...
View ArticleAI accurately predicts effects of genetic mutations in biological dark matter
Simons Foundation A new machine learning framework dubbed ExPecto can predict the effects of genetic mutations in the socalled 'dark matter' regions of the human genome. ExPecto pinpoints how specific...
View ArticleAssembly Biosciences nets $135.4mm through public offering
Assembly Biosciences Inc. developing treatments for HBV and diseases associated with the microbiome netted $135.4mm through the public sale of 4mm common shares at $36. Proceeds will support clinical...
View ArticleAssembly Biosciences nets $155.7mm through public offering
Assembly Biosciences Inc. developing treatments for HBV and diseases associated with the microbiome netted $155.7mm through the public sale of 4.6mm common shares including the overallotment at $36....
View ArticleTrivedi Global Inc. and Joy Angevin Balmer Announce the Research Results of a...
70 decrease in expression of inflammatory biomarkers. Palmetto FloridaPALMETTO Fla. PRWEB July 17 2018 Joy Angevin Balmer an evidencebased healer today announces the impact of a biofield energy treated...
View ArticleFDA Grants Breakthrough Therapy Designation for Genentechs TECENTRIQ in...
Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced that the U.S. Food and Drug Administration FDA has granted Breakthrough Therapy Designation for TECENTRIQÂ atezolizumab in...
View ArticleIMI launches new Antimicrobial Resistance Accelerator Programme as part of...
A new Antimicrobial Resistance AMR Accelerator Programme is part of new Calls for proposals launched today by the Innovative Medicines Initiative IMI. Of the other topics launched in the Calls many...
View ArticleGlobal Biologics Market Segmented by Product and Applications Growth Trends...
The global biologics market is expected to register a CAGR of about 10.5 during 20182023 the forecast period. Due to the growing demand for biologics treatment for chronic diseases North America is...
View ArticleGenentechs TECENTRIQ in Combination With Pemetrexed and PlatinumBased...
Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced that the Phase III IMpower132 study met its coprimary endpoint of progressionfree survival PFS and demonstrated that the...
View Article